Incidence of skin toxicity in squamous cell carcinoma of the head and neck treated with radiotherapy and cetuximab: A systematic review
P Bonomo, M Loi, I Desideri, E Olmetto… - Critical Reviews in …, 2017 - Elsevier
Purpose Radiotherapy plus cetuximab is an effective combination therapy for locally
advanced head and neck squamous cell carcinoma. The aim of our study was to determine …
advanced head and neck squamous cell carcinoma. The aim of our study was to determine …
Cetuximab in non-melanoma skin cancer
U Wollina - Expert opinion on biological therapy, 2012 - Taylor & Francis
Introduction: Non-melanoma skin cancer (NMSC) has become the most common cancer
with squamous cell carcinoma (SCC) as the major cause of morbidity and mortality. Review …
with squamous cell carcinoma (SCC) as the major cause of morbidity and mortality. Review …
[HTML][HTML] Receptor-tyrosine-kinase-targeted therapies for head and neck cancer
LA Elferink, VA Resto - Journal of signal transduction, 2011 - hindawi.com
Molecular therapeutics for treating epidermal growth factor receptor-(EGFR-) expressing
cancers are a specific method for treating cancers compared to general cell loss with …
cancers are a specific method for treating cancers compared to general cell loss with …
[HTML][HTML] Combined cetuximab and volumetric modulated arc-radiotherapy in advanced recurrent squamous cell carcinoma of the scalp
U Wollina, A Schreiber, K Merla, G Haroske - Dermatology Reports, 2011 - ncbi.nlm.nih.gov
A 77-year old male patient presented with an ulcerated exophytic tumor (T2, N0, M0) with
three macroscopically visible satellite metastases in the right temporo-occipital region. Mohs …
three macroscopically visible satellite metastases in the right temporo-occipital region. Mohs …
[HTML][HTML] Alergia a alfa-gal: uma revisão sistemática
MD Ferreira, LP Neto, RG Ribeiro - Arquivos de Asma, Alergia e …, 2015 - aaai-asbai.org.br
RESUMO A alergia ao carboidrato galactose-α-1, 3-galactose (alfa-gal) tem sido associada
a duas formas distintas de apresentaçao de anafilaxia: anafilaxia de início imediato durante …
a duas formas distintas de apresentaçao de anafilaxia: anafilaxia de início imediato durante …
Cetuximab has an inhibitory effect on cell motility in SCC-4 oral squamous cell carcinoma cell line
LM Furtado, IC Da Silveira, A Carneiro… - Cellular and …, 2017 - mail.cellmolbiol.org
Cetuximab is a chimeric monoclonal antibody that acts as a competitive antagonist, by
binding to EGFR. This cell signalling pathways regulates tumor progression. The oral …
binding to EGFR. This cell signalling pathways regulates tumor progression. The oral …
[PDF][PDF] Carcinoma de cabeza y cuello avanzado en pacientes ancianos no aptos para Quimioterapia/Radioterapia, en INOR
LYM Espinosa, DRM Ávila, VMM Pérez… - Revista Cubana de …, 2020 - revoncologia.sld.cu
Introducción: No existe una definición universal de paciente anciano, por lo que muchos
términos son usados. Ellos, tienen un incremento del riesgo relacionado con las toxicidades …
términos son usados. Ellos, tienen un incremento del riesgo relacionado con las toxicidades …
[PDF][PDF] Wniosek o objęcie refundacją i ustalenie ceny urzędowej leku Erbitux (cetuksymab) we wskazaniu: Leczenie pacjentów z rakiem płaskonabłonkowym w …
AOT Medycznych, WOT Medycznych - bip.aotm.gov.pl
Rozporządzenie ws. minimalnych wymagań–Rozporządzenie Ministra Zdrowia z dnia 2
kwietnia 2012 r. w sprawie minimalnych wymagań, jakie muszą spełniać analizy …
kwietnia 2012 r. w sprawie minimalnych wymagań, jakie muszą spełniać analizy …